IQ -58.19% in 24 Hours as Sharp Decline Continues
On SEP 1 2025, IQ dropped by 58.19% within 24 hours to reach $0.00325, marking the latest in a string of steep declines. Over the past seven days, the asset has plummeted by 284.35%, and over the last month by 58.19%. Year-to-date, the decline is staggering at 5397.7%. These figures underscore a dramatic deterioration in market sentiment and liquidity conditions around the asset.
The sharp price correction has drawn attention from investors and analysts alike. While no official statements have been issued by the company, the sustained drop has led some to question the underlying fundamentals and liquidity dynamics of IQ. Market participants are closely monitoring for any sign of stabilization or external catalysts that could reverse the trend. The absence of major regional or institutional support has further contributed to the downward spiral, as retail and algorithmic traders have accelerated exits from the position.
Technical indicators reinforce the bearish bias currently dominating the IQ price action. The Relative Strength Index (RSI) has fallen below 30, signaling an oversold condition, while the Moving Average Convergence Divergence (MACD) shows a strong negative divergence. These patterns suggest that sellers are maintaining control and that the asset may remain under pressure in the near term. Analysts project further downside risk if key support levels are breached without a corresponding rebound in volume or buying interest.
The technical landscape has prompted some to explore strategic scenarios involving market corrections. For example, the behavior of assets that experience a 10% daily drop is of particular interest, as it may provide insight into potential recovery patterns or follow-through declines.
Delivering real-time analysis and insights on unexpected cryptocurrency price movements to keep traders ahead of the curve.
Latest Articles
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.



Comments
No comments yet